$KPTI I am in this company first and foremost because of the management. Today’s announcement is undesired, but transparency is what I am looking for. The sales took a hit this quarter, but the company is not out, the unique mode of action from this drug still can prove itself in the future quarters through sales expansion and expansion into solid tumor. As my names says “buy low and wait”
  • 5